Pharmacology & ToxicologybioRxiv
A Strategy to Treat COVID-19 Disease with Targeted Delivery of Inhalable Liposomal Hydroxychloroquine: A Non-clinical Pharmacokinetic Study
Tien-Tzu Tai, Tzung-Ju Wu, Huey-Dong Wu…·Yee-Chun Chen
This study evaluates a liposomal HCQ formulation delivered via inhalation in rats, showing higher lung exposure and longer half-life compared to IV administration, with reduced systemic toxicity.
DOI 10.1111/cts.12923